BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With Karuna's schizophrenia program coined as the most anticip
 ated drug launch of 2024\, and 2023 bringing brand new regulatory guidanc
 e\, surging investment has reinvigorated the space with new targets\, mec
 hanisms\, and technologies to transform the mental health treatment lands
 cape.\n\nCapitalizing on a new wave of pipeline momentum\, the 7th Neurop
 sychiatric Drug Development Summit returns as the industry's premier gath
 ering\, showcasing the latest circuit-based target innovation\, EEG and d
 igital biomarker data\, in vivo and in vitro model advances\, pioneering 
 precision psychiatry approaches and more.\n\nJoin discovery\, preclinical
 \, translational\, clinical\, regulatory\, and commercial experts from Ka
 runa\, Janssen\, AbbVie\, Otsuka\, Sage Therapeutics\, Lykos\, Lundbeck\,
  Compass\, Biogen\, Delix Therapeutics\, and more as they address biophar
 ma's most pressing challenges in a collaborative atmosphere to accelerate
  the race to approval for transformative neuropsychiatric candidates.\n\n
 &nbsp\;\n\nTime: 8:00 AM - 5:00 PM\n
DTEND:20240926T170000
DTSTAMP:20260512T220334Z
DTSTART:20240924T080000
LOCATION:Hilton Boston Back Bay\, 40\, Dalton Street\, Boston\, Massachuse
 tts\, 02115\,
SEQUENCE:0
SUMMARY:With Karuna's schizophrenia program coined as the most anticipated
  drug launch of 2024\, and 2023 bringing brand new regulatory guidance\, 
 surging in...
UID:ab856f72-f8c6-4c96-9ec3-6cafbf7ac38c
END:VEVENT
END:VCALENDAR